Glenstar Minerals Inc. (CSE:GSTR)

Singular Genomics Systems Cash Flow Statement

Financials in millions CAD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Net Income	-0.79	-0.24	-0.18	-0.02
Change in Accounts Receivable	-0.03	-0.01	-0	-
Change in Accounts Payable	-0.05	0.23	0.16	0.02
Change in Other Net Operating Assets	0.05	-	-0.01	-
Operating Cash Flow	-0.62	-0.02	-0.03	-0
Capital Expenditures	-0.06	-0.01	-0.1	-0.04
Investing Cash Flow	-0.06	-0.01	-0.1	-0.04
Issuance of Common Stock	1.15	-	0.03	0.28
Other Financing Activities	-0.24	-0.09	-	-
Financing Cash Flow	0.91	-0.09	0.03	0.28
Net Cash Flow	0.24	-0.12	-0.1	0.24
Free Cash Flow	-0.67	-0.03	-0.13	-0.04
Free Cash Flow Per Share	-0.03	-0.00	-0.01	-0.01
Levered Free Cash Flow	-0.33	-0.02	-0.2	-
Unlevered Free Cash Flow	-0.33	-0.02	-0.2	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.